You keep on going on about the Zimmer buyout. I think it’s very obvious that they are not going to buy Amedica or else it would have happened already before they sold off Spine. No surgeons I know of are complaining about Co Cr or titanium being an issue. It’s all about how the market adopt new technology and for some reason you don’t want to recognize that SIN is not being accepted. Need to look at the facts and not speculation.
Market Data 
Markets 
AI
